UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000036041
Receipt No. R000041052
Scientific Title Cross-sectional and retrospective cohort study to investigate serum N-terminal pro-brain natriuretic peptide level in elderly people
Date of disclosure of the study information 2019/03/08
Last modified on 2019/02/28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Cross-sectional and retrospective cohort study to investigate serum N-terminal pro-brain natriuretic peptide level in elderly people
Acronym Serum N-terminal pro-brain natriuretic peptide level in elderly people
Scientific Title Cross-sectional and retrospective cohort study to investigate serum N-terminal pro-brain natriuretic peptide level in elderly people
Scientific Title:Acronym Serum N-terminal pro-brain natriuretic peptide level in elderly people
Region
Japan

Condition
Condition Cardiovascular disease
Hypertension
Classification by specialty
Medicine in general Cardiology Geriatrics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The aim of the present study is to investigate the association between cardiovascular risk factors and serum N-terminal pro-brain natriuretic peptide level in middle-aged and elderly people.
Basic objectives2 Others
Basic objectives -Others To evaluate the association between serum N-terminal pro-brain natriuretic peptide level and hypertension, diabetes, dyslipidemia, hyperuricemia, renal dysfunction, atrial fibrillation, ischemic heart disease, stroke, and other cardiovascular comorbidities.
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Serum N-terminal pro-brain natriuretic peptide level in elderly people
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
70 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1.Participants were recruited after undergoing general health examinations at the Health Management and Promotion Center of the Hiroshima Atomic Bomb Casualty Council.
2.They agreed to assess serum N-terminal pro-brain natriuretic peptide level.
Key exclusion criteria 1.Age of <70 years.
2.Participants had any symptoms for heart failure.
Target sample size 9300

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Nobuo Sasaki
Organization Hiroshima Atomic Bomb Casualty Council
Division name Health Management and Promotion Center
Zip code
Address 3-8-6, Senda-machi, Naka-ku, Hiroshima
TEL 082-243-2451
Email n-sasaki@gentaikyo.or.jp

Public contact
Name of contact person
1st name
Middle name
Last name Naomi Yuzono
Organization Hiroshima Atomic Bomb Casualty Council
Division name Health Management and Promotion Center
Zip code
Address 3-8-6, Senda-machi, Naka-ku, Hiroshima
TEL 082-243-2451
Homepage URL
Email n-yuzono@gentaikyo.or.jp

Sponsor
Institute Hiroshima Atomic Bomb Casualty Council
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 公益財団法人広島原爆障害対策協議会(広島県)
Hiroshima Atomic Bomb Casualty Council, Hiroshima, Japan

Other administrative information
Date of disclosure of the study information
2019 Year 03 Month 08 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 12 Month 01 Day
Date of IRB
Anticipated trial start date
2015 Year 01 Month 05 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information An observational study
Cross-sectional and retrospective cohort analysis

Management information
Registered date
2019 Year 02 Month 28 Day
Last modified on
2019 Year 02 Month 28 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041052

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.